Diabetes is a risk factor for severe periodontal disease. Major pathogens associated with periodontitis are Porphyromonas gingivalis (P. gingivalis), Bacteroides forsythus (B. forsythus) and Treponema denticola (T. denticola), all Gram-negative anaerobes. Previous studies suggest that both innate and adaptive immunity are involved in protection against periodontal infection. Innate immune responses are the first line of defense against an infection. Innate immune system cells, such as macrophages, react to common microbial surface molecules through newly discovered receptors on the macrophage cell surface called Toll-like receptors (TLRs). Preliminary studies have found that lipopolysaccharide (LPS) derived from Gram-negative bacteria regulate the expression of several different TLRs in macrophages and trigger cytokine production and expression of co-stimulatory molecules in macrophages. These events are essential for macrophage activation and initiation of specific adaptive immune responses for generation of antigen specific cells. The purpose of this project is to study innate immunity in type 1 diabetes, in particular, the role of TLR in the initiation of host immune responses against oral pathogens in periodontal infection, using the well established non-obese diabetic (NOD) mouse model of type I diabetes. NOD macrophage responses to live bacteria and LPS isolated from P. gingivalis, B. forsythus and T. denticola in terms of cytokine production, co-stimulatory molecule expression, TLR mRNA levels and TLR signal transduction will be compared to NOR mice, a diabetes resistant control strain. Our hypothesis is that a defect in innate immunity in type 1 diabetes contributes to the susceptibility to periodontal infection since it should be the interaction between the TLR and the oral pathogen that initiates immune responses. These experiments will generate novel information on innate immune responses to oral pathogens in type 1 diabetes and may lead to development of therapeutic interventions to alleviate severe periodontitis in diabetes.

Agency
National Institute of Health (NIH)
Institute
National Institute of Dental & Craniofacial Research (NIDCR)
Type
Exploratory/Developmental Grants (R21)
Project #
5R21DE014486-02
Application #
6642105
Study Section
Special Emphasis Panel (ZRG1-OBM-1 (01))
Program Officer
Bhargava, Sangeeta
Project Start
2002-08-05
Project End
2005-07-31
Budget Start
2003-08-01
Budget End
2005-07-31
Support Year
2
Fiscal Year
2003
Total Cost
$142,000
Indirect Cost
Name
University of Toledo
Department
Pharmacology
Type
Schools of Pharmacy
DUNS #
051623734
City
Toledo
State
OH
Country
United States
Zip Code
43606
Morran, M P; Alexander, L A; Slotterbeck, B D et al. (2009) Dysfunctional innate immune responsiveness to Porphyromonas gingivalis lipopolysaccharide in diabetes. Oral Microbiol Immunol 24:331-9
Morran, Michael P; McInerney, Marcia F; Pietropaolo, Massimo (2008) Innate and adaptive autoimmunity in type 1 diabetes. Pediatr Diabetes 9:152-61
Mohammad, Mohammad K; Morran, Michael; Slotterbeck, Brandon et al. (2006) Dysregulated Toll-like receptor expression and signaling in bone marrow-derived macrophages at the onset of diabetes in the non-obese diabetic mouse. Int Immunol 18:1101-13